In April 2025, the International Horizon Scanning Initiative (IHSI) unveiled its newlyredesigned website, marking a significant step forward in its mission to support governmentswith horizon scanning data for informed healthcare decision-making. The updated platform,accessible at ihsi-health.org, offers a more intuitive user experience, streamlined navigation,and enriched content to better serve policymakers, researchers, and healthcare stakeholders. The revamped […]
The International Horizon Scanning Initiative (IHSI) is pleased to announce the appointmentof Francis Arickx as the newest member of its Board. With an extensive background inpharmaceutical policy and international collaboration, Francis brings a wealth of experiencethat will support IHSI’s mission to provide timely, evidence-based insights to healthcaredecision-makers to its members. Francis Arickx succeeds Anouk Waeytens, who […]
The International Horizon Scanning Initiative (IHSI) is excited to announce the upcominglaunch of a feasibility study focused on Medical Devices (MD), set to begin in the fourthquarter of 2025. This marks a major step forward as IHSI expands its horizon scanningcapabilities beyond pharmaceuticals to include a broader range of health technologies. The study aims to assess […]
The system is based on the joined best practices of all IHSI memberstates.
A comprehensive global database tracking pharmaceutical developments from clinical trial phase I to market access approval.
Our specialised AI model utilizes LLM, NLP and machine learning, for data harvesting and curation, ensuring best-in-class data.
It is record based. Each record represents one indication of an individual pharmaceutical product; Each record has 152 unique data fields. Updated every 28 days.
Contact us
If you want to reach out to us, please leave a message and we will get in touch with you as soon as possible.